Metrika

  • citati u SCIndeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[]
  • posete u poslednjih 30 dana:4
  • preuzimanja u poslednjih 30 dana:1

Sadržaj

članak: 1 od 1  
2014, vol. 64, br. 6, str. 487-498
Učinak farmaceuta na kliničke ishode kod pacijenata u palijativnoj nezi - kratak pregled
aUniverzitet u Beogradu, Farmaceutski fakultet
bUniverzitet u Beogradu, Farmaceutski fakultet, Katedra za socijalnu farmaciju i farmaceutsko zakonodavstvo + The University of Queensland - School of Pharmacy, Brisbane, Australia
cUniverzitet u Beogradu, Farmaceutski fakultet, Katedra za socijalnu farmaciju i farmaceutsko zakonodavstvo

e-adresajovanab@pharmacy.bg.ac.rs
Projekat:
Interakcije ksenobiotika i uticaj na sisteme u biomedicini (MPNTR - 41012)
Retke bolesti: molekularna patofiziologija, dijagnostički i terapijski modaliteti i socijalni, etički i pravni aspekti (MPNTR - 41004)

Sažetak
Farmaceuti, kao najdostupniji zdravstveni radnici u vanbolničkim uslovima, mogu unaprediti zdravstvenu zaštitu pacijenata u palijativnoj nezi. Cilj ovog pregleda bio je da se proceni učinak farmaceuta (efektivnost intervencija farmaceuta) na kliničke ishode kod pacijenata u palijativnoj nezi na svim nivoima zdravstvene zaštite i u kućnim uslovima. Pretražene su dve elektronske baze naučnih radova: PubMed i SCOPUS (poslednji put u avgustu 2014. godine). Uključeni su originalni naučni radovi na engleskom jeziku, bez obzira na dizajn studije, koji se odnose na kliničke ishode kod pacijenata u palijativnoj nezi i intervencije farmaceuta. Studije koje su koristile surogatne mere ishoda, kao što je broj preporuka farmaceuta, su isključene. Od inicijalno pronađena 764 rada, samo tri su zadovoljila kriterijume za uključivanje u pregled, i svi su se odnosili na intervencije farmaceuta u vanbolničkim uslovima. Sve 3 studije su bile prikazi studija slučajeva. U svim studijama intervencije farmaceuta su dovele do stabilazicije ili poboljšanja simptoma kod pacijenata. Procenjen kvalitet dve studije je bio srednji, a jedna studija je bila lošeg kvaliteta. Kako je broj studija i nivo dokaza ograničen, a rezultati studija ukazuju da intervencije farmaceuta potencijalno mogu imati pozitivan uticaj na kliničke ishode kod pacijenata u palijativnoj nezi, potrebna su dalja istraživanja u ovoj oblasti.
Reference
Akers, J. (2009) Systematic reviews: CRD's guidance for undertaking reviews in health care. Centre for Reviews and Dissemination, Reviews UoYCF Dissemination [Internet] [cited 2014 Jul 11] Available from: http://www.york.ac.uk/inst/crd/pdf/Systematic_Reviews.pdf
Al-Jumah, K.A., Qureshi, N.A. (2012) Impact of pharmacist interventions on patients' adherence to antidepressants and patient-reported outcomes: a systematic review. Patient preference and adherence, 6: 87-100
Australia PC. (2005) Standards for providing quality palliative care for all Australians. Palliative Care Australia Incorporated, [Internet] [cited 2014 Aug 29] Available from http://www.palliativecare.org.au/portals/46/resources/StandardsPalliativeCare.pdf>;
Bakitas, M., Lyons, K.D., Hegel, M.T., Balan, S., Barnett, K.N., Brokaw, F.C., Byock, I.R., Hull, J.G., Li, Z., Mckinstry, E., Seville, J.L., Ahles, T.A. (2009) The project ENABLE II randomized controlled trial to improve palliative care for rural patients with advanced cancer: Baseline findings, methodological challenges, and solutions. Palliative and Supportive Care, 7(01): 75
Charrois, T.L., Durec, T., Tsuyuki, R.T. (2009) Systematic reviews of pharmacy practice research: methodologic issues in searching, evaluating, interpreting, and disseminating results. Annals of pharmacotherapy, 43(1): 118-22
Chisholm-Burns, M.A., Graff, Z.J.S., Lee, J.K., Spivey, C.A., Slack, M., Herrier, R.N., Hall-Lipsy, E., Abraham, I., Palmer, J. (2010) Economic effects of pharmacists on health outcomes in the United States: A systematic review. American journal of health-system pharmacy, 67(19): 1624-34
Craig, P., Dieppe, P., Macintyre, S., Michie, S., Nazareth, I., Petticrew, M. (2008) Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ, 337(sep29 1): a1655-a1655
Flemming, K., Adamson, J., Atkin, K. (2008) Improving the effectiveness of interventions in palliative care: the potential role of qualitative research in enhancing evidence from randomized controlled trials. Palliative Medicine, 22(2): 123-131
Gagnon, L., Fairchild, A., Pituskin, E., Dutka, J., Chambers, C. (2012) Optimizing pain relief in a specialized outpatient palliative radiotherapy clinic: contributions of a clinical pharmacist. Journal of oncology pharmacy practice, 18(1): 76-83
Gallagher, J., Byrne, S., Woods, N., Lynch, D., McCarthy, S. (2014) Cost-outcome description of clinical pharmacist interventions in a university teaching hospital. BMC health services research, 14: 177
Harding, R., Powell, R.A., Kiyange, F., Downing, J., Mwangi-Powell, F. (2010) Provision of Pain- and Symptom-Relieving Drugs for HIV/AIDS in Sub-Saharan Africa. Journal of Pain and Symptom Management, 40(3): 405-415
Harding, R., Simon, S.T., Benalia, H., Downing, J., Daveson, B.A., Higginson, I.J., Bausewein, C. (2011) The PRISMA Symposium 1: outcome tool use. Disharmony in European outcomes research for palliative and advanced disease care: too many tools in practice. Journal of pain and symptom management, 42(4): 493-500
Higgins, J.P.T., Green, S., ur. (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0. Cochrane Collaboration, www.cochrane-handbook.org
Latuga, N.M., Wahler, R.G., Monte, S.V. (2012) A National Survey of Hospice Administrator and Pharmacist Perspectives on Pharmacist Services and the Impact on Medication Requirements and Cost. American Journal of Hospice and Palliative Medicine, 29(7): 546-554
Lindenmeyer, A., Hearnshaw, H., Vermeire, E., van Royen, P., Wens, J., Biot, Y. (2006) Interventions to improve adherence to medication in people with type 2 diabetes mellitus: a review of the literature on the role of pharmacists. Journal of Clinical Pharmacy and Therapeutics, 31(5): 409-419
Needham, D.S., Wong, I.C.K., Campion, P.D. (2002) Evaluation of the effectiveness of UK community pharmacists' interventions in community palliative care. Palliative medicine, 16(3): 219-25
Norrström, B., Cannerfelt, I., Frid, H., Roos, K., Ramström, H. (2010) Introduction of pharmaceutical expertise in a palliative care team in Sweden. Pharmacy World and Science, 32(6): 829-834
Nwagwu, W.E., Adegunwa, G.O., Soyannwo, O.A. (2013) ICT and collaborative management of terminal cancer patients at the University College Hospital, Ibadan, Nigeria. Health and Technology, 3(4): 309-325
O’Connor, M., Fisher, C., French, L., Halkett, G., Jiwa, M., Hughes, J. (2011) Exploring the community pharmacist's role in palliative care: Focusing on the person not just the prescription. Patient Education and Counseling, 83(3): 458-464
Pande, S., Hiller, J.E., Nkansah, N., Bero, L. (2013) The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries. Cochrane Database Syst Rev., 2
Wilson, S., Wahler, R., Brown, J., Doloresco, F., Monte, S.V. (2011) Impact of pharmacist intervention on clinical outcomes in the palliative care setting. American journal of hospice and palliative care, 28(5): 316-20
 

O članku

jezik rada: srpski
vrsta rada: stručni članak
DOI: 10.5937/arhfarm1406487B
objavljen u SCIndeksu: 26.05.2015.

Povezani članci

Arhiv za farmaciju (2011)
Farmaceutska zdravstvena zaštita u terapiji dijabetesa
Vezmar-Kovačević Sandra, i dr.

Acta fac medic Naissensis (2008)
Klinička praksa bazirana na dokazima i Kohran Hepato-Bilijarna Grupa
Gluud Christian, i dr.